The Current Status of Metastatic Prostate Cancer Treatment

In May 2007, the American Urological Association published updated guidelines for the management of clinically localized prostate cancer. Despite high response rates to initial hormone therapy, treatment remains non-curative and the disease will ultimately progress in the majority of patients. To assist in understanding the contents of these updated guidelines, this supplement is a review by Dr. Nicholas Vogelzang and colleagues from the Nevada Cancer Institute designed to address the current roles of hormonal and chemotherapy in the management of metastatic prostate cancer. This supplement is supported by an unrestricted educational grant from sanofi aventis.

 

 Download a PDF of the full issue